Your browser doesn't support javascript.
loading
Adropin reduces blood glucose levels in mice by limiting hepatic glucose production.
Thapa, Dharendra; Xie, Bingxian; Manning, Janet R; Zhang, Manling; Stoner, Michael W; Huckestein, Brydie R; Edmunds, Lia R; Zhang, Xueyang; Dedousis, Nikolaos L; O'Doherty, Robert M; Jurczak, Michael J; Scott, Iain.
Afiliación
  • Thapa D; Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Xie B; Department of Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Manning JR; Department of Medicine, Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Zhang M; Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Stoner MW; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Huckestein BR; Department of Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Edmunds LR; Department of Medicine, Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Zhang X; Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Dedousis NL; Department of Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • O'Doherty RM; Department of Medicine, Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Jurczak MJ; Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Scott I; Department of Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Physiol Rep ; 7(8): e14043, 2019 04.
Article en En | MEDLINE | ID: mdl-31004398

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucemia / Fármacos Antiobesidad / Péptidos y Proteínas de Señalización Intercelular / Gluconeogénesis / Hígado Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Physiol Rep Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucemia / Fármacos Antiobesidad / Péptidos y Proteínas de Señalización Intercelular / Gluconeogénesis / Hígado Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Physiol Rep Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos